| Literature DB >> 35189692 |
Crystal W Cené1,2, Xiaoyan Iris Leng3, Khushnood Faraz1, Matthew Allison4, Khadijah Breathett5, Chloe Bird6, Mace Coday7, Giselle Corbie-Smith1, Randi Foraker8, Nkechinyere N Ijioma9, Milagros C Rosal10, Shawnita Sealy-Jefferson11, Tetyana P Shippee12, Candyce H Kroenke13.
Abstract
Background The association of social isolation or lack of social network ties in older adults is unknown. This knowledge gap is important since the risk of heart failure (HF) and social isolation increase with age. The study examines whether social isolation is associated with incident HF in older women, and examines depressive symptoms as a potential mediator and age and race and ethnicity as effect modifiers. Methods and Results This study included 44 174 postmenopausal women of diverse race and ethnicity from the WHI (Women's Health Initiative) study who underwent annual assessment for HF adjudication from baseline enrollment (1993-1998) through 2018. We conducted a mediation analysis to examine depressive symptoms as a potential mediator and further examined effect modification by age and race and ethnicity. Incident HF requiring hospitalization was the main outcome. Social isolation was a composite variable based on marital/partner status, religious ties, and community ties. Depressive symptoms were assessed using CES-D (Center for Epidemiology Studies-Depression). Over a median follow-up of 15.0 years, we analyzed data from 36 457 women, and 2364 (6.5%) incident HF cases occurred; 2510 (6.9%) participants were socially isolated. In multivariable analyses adjusted for sociodemographic, behavioral, clinical, and general health/functioning; socially isolated women had a higher risk of incident HF than nonisolated women (HR, 1.23; 95% CI, 1.08-1.41). Adding depressive symptoms in the model did not change this association (HR, 1.22; 95% CI, 1.07-1.40). Neither race and ethnicity nor age moderated the association between social isolation and incident HF. Conclusions Socially isolated older women are at increased risk for developing HF, independent of traditional HF risk factors. Registration URL: http://www.clinicaltrials.gov; Unique identifier: NCT00000611.Entities:
Keywords: heart failure; older adults; social isolation; women
Mesh:
Year: 2022 PMID: 35189692 PMCID: PMC9075097 DOI: 10.1161/JAHA.120.022907
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Analytic sample.
BMI indicates body mass index; and HF, heart failure; SF36, Short Form 36.
Participant Characteristics at Baseline
| Overall, n (%) | Not socially isolated, n (%) | Socially isolated, n (%) |
| |
|---|---|---|---|---|
| Total | 36 457 | 33 974 | 2510 | |
| Age (y), mean (SD) | 62.6 (7.2) | 62.6 (7.2) | 62.6 (7.3) | 0.73 |
| Race and ethnicity | ||||
| American Indian/Alaskan Native | 107 (0.3) | 94 (0.3) | 13 (0.5) | <0.001 |
| Asian/Pacific Islander | 481 (1.3) | 434 (1.3) | 47 (1.9) | |
| Black | 11 960 (32.8) | 11 324 (33.4) | 636 (25.3) | |
| Hispanic/Latino | 5058 (13.9) | 4760 (14.0) | 298 (11.9) | |
| White | 18 566 (50.9) | 17 064 (50.3) | 1502 (59.8) | |
| Other/multiple | 285 (0.8) | 271 (0.8) | 14 (0.6) | |
| Education | ||||
| Less than high school | 3456 (9.5) | 3199 (9.4) | 257 (10.2) | 0.005 |
| High school/vocational training | 11 111 (30.5) | 10 365 (30.5) | 746 (29.7) | |
| Some college/associate degree | 10 157 (27.9) | 9397 (27.7) | 760 (30.3) | |
| College/graduate | 11 733 (32.2) | 10 986 (32.4) | 747 (29.8) | |
| Observational study | ||||
| No | 27 231 (74.7) | 25 255 (74.4) | 1976 (78.7) | <0.001 |
| Yes | 9226 (25.3) | 8692 (25.6) | 534 (21.3) | |
| Hormone therapy arm | <0.001 | |||
| Not in hormone therapy trial | 13 704 (37.6) | 12 978 (38.2) | 726 (28.9) | |
| CEE alone control | 4386 (12.0) | 4033 (11.9) | 353 (14.1) | |
| CEE alone intervention | 4404 (12.1) | 4046 (11.9) | 358 (14.3) | |
| CEE+MPA control | 7053 (19.4) | 6483 (19.1) | 570 (22.7) | |
| CEE+MPA intervention | 6910 (18.9) | 6407 (18.9) | 503 (20.0) | |
| Depressive symptom | ||||
| No | 30 933 (87.3) | 28 976 (87.8) | 1957 (80.7) | <0.001 |
| Yes | 4490 (12.7) | 4023 (12.2) | 467 (19.3) | |
| Smoking status | ||||
| Never smoked | 18 676 (51.2) | 17 790 (52.4) | 886 (35.3) | <0.001 |
| Past smoker | 14 095 (38.7) | 13 020 (38.4) | 1075 (42.8) | |
| Current smoker | 3686 (10.1) | 3137 (9.2) | 549 (21.9) | |
| BMI (kg/m2), mean (SD) | 29.6 (6.3) | 29.6 (6.2) | 29.7 (6.6) | 0.30 |
| Obesity | ||||
| No | 21 526 (59.0) | 20 062 (59.1) | 1464 (58.3) | 0.45 |
| Yes | 14 931 (41.0) | 13 885 (40.9) | 1046 (41.7) | |
| High cholesterol requiring pills | ||||
| No | 31 315 (85.9) | 29 145 (85.9) | 2170 (86.5) | 0.40 |
| Yes | 5142 (14.1) | 4802 (14.1) | 340 (13.5) | |
| Hypertension | ||||
| Never hypertensive | 22 298 (61.2) | 20 704 (61.0) | 1594 (63.5) | <0.001 |
| Current/treated | 3294 (9.0) | 3023 (8.9) | 271 (10.8) | |
| Current/untreated | 10 865 (29.8) | 10 220 (30.1) | 645 (25.7) | |
| Treated diabetes | ||||
| No | 33 783 (92.7) | 31 467 (92.7) | 2316 (92.3) | 0.43 |
| Yes | 2674 (7.3) | 2480 (7.3) | 194 (7.7) | |
| Sedentary behavior | ||||
| No | 15 129 (41.5) | 14 277 (42.1) | 852 (33.9) | <0.001 |
| Yes | 21 328 (58.5) | 19 670 (57.9) | 1658 (66.1) | |
| Prevalent CVD | ||||
| No | 33 788 (92.7) | 31 480 (92.7) | 2308 (92.0) | 0.15 |
| Yes | 2669 (7.3) | 2467 (7.3) | 202 (8.0) | |
| Incident MI | ||||
| No | 34 928 (95.8) | 32 549 (95.9) | 2379 (94.8) | 0.008 |
| Yes | 1529 (4.2) | 1398 (4.1) | 131 (5.2) | |
| General health | ||||
| Excellent | 4865 (13.3) | 4545 (13.4) | 320 (12.7) | <0.001 |
| Very good | 13 582 (37.3) | 12 700 (37.4) | 882 (35.1) | |
| Good | 13 549 (37.2) | 12 662 (37.3) | 887 (35.3) | |
| Fair | 4095 (11.2) | 3726 (11.0) | 369 (14.7) | |
| Poor | 366 (1.0) | 314 (0.9) | 52 (2.1) | |
| SF36—physical functioning, mean (SD) | 79.0 (21.5) | 79.2 (21.3) | 76.2 (23.5) | <0.001 |
BMI indicates body mass index; CEE, combined equine estrogens; CVD, cardiovascular disease; MI, myocardial infarction; and MPA, medroxyprogesterone acetate; SF36, Short Form 36.
Association Between Incident HF Hospitalization and Social Isolation (Total Number of Observations: 36 457; Total Number of Events: 2364)
| Predictor | Model 0 | Model 1 | Model 2 | Interaction | Interaction | |||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) |
| |||
| Social isolation | 1.56 (1.37–1.78) | <0.001 | 1.23 (1.08–1.41) | 0.002 | 1.22 (1.07–1.40) | 0.003 | 0.29 | 0.94 |
| Not married or intimate | 1.25 (1.15–1.35) | <0.001 | 1.11 (1.02–1.20) | 0.020 | 1.10 (1.01–1.20) | 0.024 | 0.21 | 0.16 |
| No religion tie | 1.19 (1.09–1.30) | <0.001 | 1.06 (0.97–1.16) | 0.22 | 1.06 (0.97–1.16) | 0.23 | 0.50 | 0.92 |
| No community tie | 1.15 (1.06–1.25) | <0.001 | 1.01 (0.93–1.10) | 0.75 | 1.01 (0.93–1.10) | 0.77 | 0.48 | 0.47 |
| Live alone | 1.00 (0.92–1.09) | 0.98 | 0.97 (0.89–1.06) | 0.11 | 0.97 (0.89–1.06) | 0.52 | 0.14 | 0.27 |
Model 0: adjusted for age, race, education, study arm (clinical trial vs observational study), hormone therapy arm.
Model 1: Adjusted for age, race, education, study arm (clinical trial vs observational study), hormone therapy arm, treated diabetes, hypertension status, treated high cholesterol, obesity, sedentary behavior, prevalent cardiovascular disease and incident myocardial infarction, smoking, self‐rated health status, and physical functioning.
Model 2: model I plus most recent depressive symptoms as time‐varying covariate.
Interaction between race and ethnicity and predictor for Model 1.
Interaction between baseline age and predictor for Model 1.
The sum of not married, no religion tie, and no community tie was calculated. If the sum is 3, then social isolation=“Yes”.
Defined as not at all in the past month.
Figure 2Kaplan–Meier product limit estimate of the cumulative incidence of heart failure hospitalization over time by social isolation status (socially isolated vs nonisolated) at baseline.
Figure 3Conceptual model of direct, mediating, and moderating effects of social isolation on incident HF hospitalization in 36 457 older women (mean age, 62 years) from the WHI (Women's Health Initiative) study over mean follow‐up of 15 years.
HRs of Incidence HF Hospitalization of Covariates in Model 1
| Covariates | HR (95% CI) |
|
|---|---|---|
| Baseline age per year | 1.09 (1.09–1.10) | <0.001 |
| Race and ethnicity (vs White) | <0.001 | |
| Asian/Pacific Islander | 0.71 (0.46–1.11) | |
| Black | 0.78 (0.66–0.91) | |
| Hispanic/Latino | 0.61 (0.49–0.76) | |
| Other | 0.97 (0.67–1.40) | |
| Education (vs college/graduate) | 0.32 | |
| Less than high school | 1.08 (0.92–1.27) | |
| High school/vocational training | 1.19 (0.99–1.22) | |
| Some college/associate degree | 1.08 (0.97–1.20) | |
| Treated diabetes | 2.35 (2.08–2.64) | <0.001 |
| Hypertension | <0.001 | |
| Never hypertensive | 0.58 (0.53–0.64) | |
| Controlled hypertension | 0.70 (0.60–0.81) | |
| Treated high cholesterol | 0.96 (0.86–1.07) | 0.43 |
| Obesity (BMI ≥30) | 1.34 (1.23–1.47) | <0.001 |
| Sedentary behavior | 1.09 (1.00–1.19) | 0.06 |
| Smoking status (vs current smoker) | <0.001 | |
| Never smoked | 0.45 (0.39–0.51) | |
| Past smoker | 0.55 (0.48–0.63) | |
| Prevalent CVD | 1.82 (1.62–2.05) | <0.001 |
| Incident MI | 2.90 (2.53–3.33) | <0.001 |
| General health (vs excellent) | 0.002 | |
| Very good | 1.11 (0.95–1.29) | |
| Good | 1.15 (0.98–1.34) | |
| Fair | 1.44 (1.19–1.76) | |
| Poor | 1.39 (0.94–2.05) | |
| Physical functioning per 1 unit increase | 0.991 (0.989–0.993) | <0.001 |
| Hormone therapy arm (vs not in hormone therapy trial) | 0.002 | |
| CEE alone control | 1.41 (1.14–1.73) | |
| CEE alone intervention | 1.36 (1.10–1.68) | |
| CEE+MPA control | 1.18 (0.95–1.46) | |
| CEE+MPA intervention | 1.24 (1.00–1.53) |
BMI indicates body mass index; CEE, combined equine estrogens; CVD, cardiovascular disease; HF, heart failure; HR, hazard ratio; MI, myocardial infarction; and MPA, medroxyprogesterone acetate.